Publication: Cost Effectiveness of Rivaroxaban in Coronary Artery Disease and/or Peripheral Artery Disease for 5 Differen Patient Sub-Groups in Turkey
| dc.contributor.author | Kockaya, G. | |
| dc.contributor.author | Ergin, Oguzhan G. | |
| dc.contributor.author | Caliskan, Z. | |
| dc.contributor.author | Okcun, S. | |
| dc.contributor.author | Kurnaz, M. | |
| dc.contributor.author | Buyuktuna, N. | |
| dc.contributor.author | Saylan, M. | |
| dc.date.accessioned | 2020-06-21T12:25:45Z | |
| dc.date.available | 2020-06-21T12:25:45Z | |
| dc.date.issued | 2019 | |
| dc.department | OMÜ | en_US |
| dc.department-temp | [Kockaya, G.] ECONiX, Ankara, Turkey -- [Ergin, Oguzhan G.] 19 Mayis Univ, Samsun, Turkey -- [Caliskan, Z.] Hacettepe Univ, Ankara, Turkey -- [Okcun, S. -- Kurnaz, M.] ECONiX, Istanbul, Turkey -- [Buyuktuna, N. -- Buyukisik, T. | en_US |
| dc.description.abstract | … | en_US |
| dc.identifier.endpage | S549 | en_US |
| dc.identifier.issn | 1098-3015 | |
| dc.identifier.issn | 1524-4733 | |
| dc.identifier.startpage | S549 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/10513 | |
| dc.identifier.volume | 22 | en_US |
| dc.identifier.wos | WOS:000503167001056 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science Inc | en_US |
| dc.relation.journal | Value in Health | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Cost Effectiveness of Rivaroxaban in Coronary Artery Disease and/or Peripheral Artery Disease for 5 Differen Patient Sub-Groups in Turkey | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
